Ascendis Pharma (ASND) PT Raised to $140 at Morgan Stanley

May 15, 2024 4:41 PM EDT Send to a Friend
Morgan Stanley analyst Vikram Purohit raised the price target on Ascendis Pharma (NASDAQ: ASND) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login